These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 17684807

  • 1. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D, Wheeler CM.
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ, O'Shea M, Diaz M, Kim SY.
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

  • 9. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Oct 14; 60(40):1382-4. PubMed ID: 21993342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM.
    Public Health Genomics; 2009 Aug 19; 12(5-6):319-30. PubMed ID: 19684444
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [Abstract] [Full Text] [Related]

  • 18. [Vaccines against human papillomavirus (HPV); between registration and implementation].
    van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J.
    Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):987-92. PubMed ID: 18549172
    [Abstract] [Full Text] [Related]

  • 19. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.
    Vaccine; 2008 Jul 29; 26(32):4080-93. PubMed ID: 18550229
    [Abstract] [Full Text] [Related]

  • 20. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Downs LS, Scarinci I, Einstein MH, Collins Y, Flowers L.
    Gynecol Oncol; 2010 Jun 29; 117(3):486-90. PubMed ID: 20303156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.